A case of chronic progressive myelopathy.
Acute myelitis and optic neuritis are the main clinical features of patients with neuromyelitis optica (NMO), which usually appears as a relapsing-remitting course of disease that worsens over days and improves over weeks. We present a patient with chronic progressive myelitis over a 4-month period without remission as having a limited form of NMO that improved after plasmapheresis. Plasmapheresis may benefit patients with chronic progressive myelitis, which may be a manifestation of NMO, as well as those with a relapsing-remitting course of NMO.
Kim
Jun-Soon
JS
Department of Neurology, Seoul National University, College of Medicine, Seoul, Korea.
Park
Young Ho
YH
Kim
Sung-Min
SM
Kim
Su-hyun
SH
Park
Kyung Seok
KS
Sung
Jung-Joon
JJ
Lee
Kwang-Woo
KW
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D051401:Aquaporin 4 / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D053580:Muscle Strength / Q000502:physiology; D009460:Neurologic Examination; D009471:Neuromyelitis Optica / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy; D010956:Plasmapheresis; D013116:Spinal Cord / Q000473:pathology
D000893:Anti-Inflammatory Agents; D051401:Aquaporin 4; D001323:Autoantibodies; D008775:Methylprednisolone